Redmile Group, LLC - Director, 10%+ Owner at Fate Therapeutics Inc

Insider Transactions and Holdings

Entity Type: Company
Role: Director, 10%+ Owner
Stock Symbol: FATE on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Redmile Group, LLC - trading volume in the past year for Fate Therapeutics Inc

	Shares	%	Avg Price	Total $
Buys	+398K	53.8%	$1.68	+$669K
Sells	-342K	46.2%	$1.68	-$574K
Net	+56.3K	7.6%		+$94.6K

Holdings reported by Redmile Group, LLC for Fate Therapeutics Inc

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Class A Convertible Preferred Stock	2.76M	$23.1M	$8.40	Dec 20, 2024	Indirect	Common Stock
Common Stock	12.9M	$21.6M	$1.68	Dec 20, 2024	Indirect
Cash-settled Swaps	503K	$845K	$1.68	Dec 20, 2024	Indirect	Common Stock
Stock Option (Right to Buy)	55K	$109K	$2.73	May 29, 2025	Indirect	Common Stock

Transactions reported by Redmile Group, LLC for Fate Therapeutics Inc

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.